#United States #New York #Class Action #Gross Law Firm #Organon & Co

Organon & Co. Class Action Update

The Gross Law Firm has issued a crucial notice to shareholders of Organon & Co. (NYSE: OGN). Investors who acquired shares during the specified class period, from October 31, 2024, to April 30, 2025, are encouraged to connect with the firm regarding the opportunity for lead plaintiff appointment in a pending class action lawsuit.

Background of the Class Action

According to the allegations laid out in the complaint
, the defendants made excessively positive statements to investors while simultaneously providing materially false and misleading information. They allegedly concealed critical facts regarding Organon’s priorities, particularly concerning capital allocation and the impacts on quarterly dividends.

The company’s debt reduction strategy, post-acquisition of Dermavant, was not disclosed as a high priority, which ultimately led to a significant decrease of 70% in the regular quarterly dividend. Following this announcement, the stock price of Organon experienced a drastic drop. From a closing price of $12.93 on April 30, 2025, the share price plummeted to $9.45 the next day, representing a staggering decline of more than 27% within a single trading session.

Important Deadlines

The deadline to register as a lead plaintiff is July 22, 2025. Shareholders are advised not to delay in registering for this class action. Interested parties can secure their claim by submitting their information through the firm’s designated form. By registering, shareholders will also gain access to a portfolio monitoring service that provides status updates throughout the entire lifecycle of the case.

Next Steps for Affected Shareholders

Once registered, shareholders who purchased shares of OGN within the designated timeframe will receive updates about the case's progression. The Gross Law Firm emphasizes that there are no costs or obligations for investors to participate in this class action.

Why Choose the Gross Law Firm?

As a nationally recognized class action litigation firm, the Gross Law Firm is dedicated to protecting the rights of investors who may have lost money due to deceitful practices and non-transparent business conduct. The firm advocates for responsible corporate behavior and seeks recovery for investors who experience losses due to misleading information or omission by companies, causing unnecessary inflation in stock prices. The firm clearly states that past outcomes do not guarantee similar results in future cases.

Conclusion

Investors in Organon & Co. are urged to pay close attention to the developments in this class action lawsuit, as the upcoming deadline could significantly impact their investments. Ensure you register your details with the firm to stay informed and involved.

For further information or assistance, investors can contact:

The Gross Law Firm
15 West 38th Street, 12th Floor
New York, NY, 10018
Email: info@grosslawfirm.com
Phone: (646) 453-8903

• ---